Bioresorbable scaffolds: Current knowledge, potentialities and limitations experienced during their first clinical applications

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 11-21

  Bourantas, Christos V ^a   Onuma, Yoshinobu ^a   Farooq, Vasim ^a   Zhang, Yaojun ^a   Garcia Garcia, Hector M ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bioresorbable scaffolds; Coronary artery disease; Drug eluting stents

Indexed keywords

BIOMATERIAL; BIORESORBABLE MAGNESIUM SCAFFOLD; BIORESORBABLE SCAFFOLD; EVEROLIMUS; HEPARIN; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONTROLLED DRUG RELEASE; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DEVICE APPROVAL; DRUG ELUTING STENT; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; METAL STENT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SHEAR STRESS; STENT THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ABSORBABLE IMPLANTS; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 84878529444     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.093     Document Type: Review

References (67)

1. M. Nobuyoshi, T. Kimura, and H. Nosaka Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients J Am Coll Cardiol 12 3 1988 616 623
2. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 8 1994 489 495
3. U. Sigwart, P. Urban, and S. Golf Emergency stenting for acute occlusion after coronary balloon angioplasty Circulation 78 5 Pt 1 1988 1121 1127
4. J. Al Suwaidi, P.B. Berger, and D.R. Holmes Jr. Coronary artery stents JAMA 284 14 2000 1828 1836
5. G.W. Stone, S.G. Ellis, and L. Cannon Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 10 2005 1215 1223
6. M. Sabate, P. Jimenez-Quevedo, and D.J. Angiolillo Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial Circulation 112 14 2005 2175 2183
7. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 1 2006 193 202
8. N. Guo, A. Maehara, and G.S. Mintz Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 122 11 2010 1077 1084
9. P. Barlis, E. Regar, and P.W. Serruys An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study Eur Heart J 31 2 2010 165 176
10. P.W. Serruys, H.M. Garcia-Garcia, and Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 1 2012 16-25b
11. J.J. Wentzel, D.M. Whelan, and W.J. van der Giessen Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution J Biomech 33 10 2000 1287 1295
12. A. Tortoriello, and G. Pedrizzetti Flow-tissue interaction with compliance mismatch in a model stented artery J Biomech 37 1 2004 1 11
13. F.J. Gijsen, R.M. Oortman, and J.J. Wentzel Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries Am J Cardiol 92 11 2003 1325 1328
14. M.I. Papafaklis, C.V. Bourantas, and P.E. Theodorakis The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans JACC Cardiovasc Interv 3 11 2010 1181 1189
15. N. Suzuki, H. Nanda, and D.J. Angiolillo Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus Int J Cardiovasc Imaging 24 4 2008 357 364
16. A.W. Orr, N.E. Hastings, B.R. Blackman, and B.R. Wamhoff Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis J Vasc Res 47 2 2010 168 180
17. G. Nakazawa, F. Otsuka, and M. Nakano The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 11 2011 1314 1322
18. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 6 2004 701 705
19. J. Gomez-Lara, H.M. Garcia-Garcia, and Y. Onuma A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents JACC Cardiovasc Interv 3 11 2010 1190 1198
20. M. Vorpahl, A.V. Finn, M. Nakano, and R. Virmani The bioabsorption process: tissue and cellular mechanisms and outcomes EuroIntervention 5 Suppl. F 2009 F28 F35
21. P.W. Serruys, Y. Onuma, and D. Dudek Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 15 2011 1578 1588
22. H. Tamai, K. Igaki, and E. Kyo Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans Circulation 102 4 2000 399 404
23. T. Akiyama, I. Moussa, and B. Reimers Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels J Am Coll Cardiol 32 6 1998 1610 1618
24. S. Nishio, K. Kosuga, and K. Igaki Long term (> 10 years) clinical outcomes of first-in-man biodegradable poly-L-lactic acid coronary stents: Igaki-Tamai stents Circulation 125 19 2012 2343 2353
25. Y. Onuma, S. Garg, and T. Okamura Ten-year follow-up of the IGAKI-TAMAI stent. A posthumous tribute to the scientific work of Dr. Hideo Tamai EuroIntervention 5 Suppl. F 2009 F109 F111
26. M.J. Post, A.N. de Graaf-Bos, H.G. van Zanten, P.G. de Groot, J.J. Sixma, and C. Borst Thrombogenicity of the human arterial wall after interventional thermal injury J Vasc Res 33 2 1996 156 163
27. G. Biamino, A. Schmidt, and D. Scheinert Treatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS Study J Endovasc Ther 12 1 2005 I 5
28. B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, and A. Haverich Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 89 6 2003 651 656
29. R. Erbel, C. Di Mario, and J. Bartunek Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial Lancet 369 9576 2007 1869 1875
30. G. Ghimire, J. Spiro, and R. Kharbanda Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents EuroIntervention 4 4 2009 481 484
31. R. Waksman Lessons learnt from Preclinical Studies of Magnesium Scaffolds (Biotronik's DREAMS program) PCR focus group on bioresorbable vascular scaffolds March 28 2012 [Rotterdam NL]
32. M. Haude From PROGRESS to DREAMS PCR focus group on bioresorbable vascular scaffolds March 2012 [Rotterdam NL]
33. J.P. Oberhauser, S. Hossainy, and R.J. Rapoza Design principles and performance of bioresorbable polymeric coronary scaffolds EuroIntervention 5 Suppl. F 2009 F15 F22
34. P.W. Serruys, J.A. Ormiston, and Y. Onuma A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 9667 2009 897 910
35. S. Tanimoto, N. Bruining, and R.T. van Domburg Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology J Am Coll Cardiol 52 20 2008 1616 1620
36. B.E. Claessen, M.A. Beijk, and V. Legrand Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial Circ Cardiovasc Interv 2 4 2009 339 347
37. P.W. Serruys, Y. Onuma, and J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 22 2010 2301 2312
38. P. Serruys, Y. Onuma on behalf of the ABSORB A & B investigators ABSORB Cohort B: 6 months, 12 months, 18 months and 24 months follow-up PCR focus group on bioresorbable vascular scaffolds March 2012 [Rotterdam NL,]
39. E. Grube Bioabsorbable stent The Boston Scientific and REVA technology May 2009 EuroPCR Barcelona, Spain
40. R. Jabara, N. Chronos, and K. Robinson Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating Catheter Cardiovasc Interv 72 2 2008 186 194
41. R. Jabara, L. Pendyala, S. Geva, J. Chen, N. Chronos, and K. Robinson Novel fully bioabsorbable salicylate-based sirolimus-eluting stent EuroIntervention 5 Suppl. F 2009 F58 F64
42. R. Jabara Glimpse into the future: bioabsorbable stent aiming to restore vascular integrity May 2009 EuroPCR Barcelona, Spain
43. S. Verheye Desolve first in man study preliminary results PCR focus group on bioresorbable vascular scaffolds March 2012 [Rotterdam NL]
44. G. Sarno, I. Decraemer, and P.K. Vanhoenacker On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography JACC Cardiovasc Interv 2 6 2009 550 557
45. J.M. Miller, C.E. Rochitte, and M. Dewey Diagnostic performance of coronary angiography by 64-row CT N Engl J Med 359 22 2008 2324 2336
46. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 20 2010 2501 2555
47. S. Haraldsdottir, T. Gudnason, and A.F. Sigurdsson Diagnostic accuracy of 64-slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient population Eur J Radiol 76 2 2010 188 194
48. O. Gaemperli, T. Schepis, and I. Valenta Cardiac image fusion from stand-alone SPECT and CT: clinical experience J Nucl Med 48 5 2007 696 703
49. O. Gaemperli, L. Husmann, and T. Schepis Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? Eur Heart J 30 23 2009 2921 2929
50. M. Otsuka, S. Tanimoto, and G. Sianos "Radio-lucent" and "radio-opaque" coronary stents characterized by multislice computed tomography Int J Cardiol 132 1 2009 e8 e10
51. Serruys PW, Girasis C, Papadopoulou SL, Onuma Y. Can multislice computed tomography provide practitioners with quantitative luminography, plaque characterization and non-invasive fractional flow reserve, all in one study? The ultimate dream for non-invasive imaging. Eurointervention (in press).
52. S. Brugaletta, M.D. Radu, and H.M. Garcia-Garcia Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis 221 1 2012 106 112
53. S. Ramcharitar, N. Gonzalo, and R.J. van Geuns First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol 6 5 2009 374 378
54. J.J. Wykrzykowska, R. Diletti, and J.L. Gutierrez-Chico Plaque sealing and passivation with a mechanical self-expanding low outward Nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdham for Investigation and Treatment of TFCA (SECRITT) EuroIntervention 8 8 2012 Dec 20 945 954
55. L. Liu, J.A. Gardecki, and S.K. Nadkarni Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography Nat Med 17 8 2011 1010 1014
56. I.S. Rogers, K. Nasir, and A.L. Figueroa Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina JACC Cardiovasc Imaging 3 4 2010 388 397
57. F.A. Jaffer, M.A. Calfon, and A. Rosenthal Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury J Am Coll Cardiol 57 25 2011 2516 2526
58. B.D. Gogas, R.J. van Geuns, and V. Farooq Three-dimensional reconstruction of the post-dilated ABSORB everolimus-eluting bioresorbable vascular scaffold in a true bifurcation lesion for flow restoration JACC Cardiovasc Interv 4 10 2011 1149 1150
59. T. Okamura, P.W. Serruys, and E. Regar Cardiovascular flashlight. The fate of bioresorbable struts located at a side branch ostium: serial three-dimensional optical coherence tomography assessment Eur Heart J 31 17 2010 2179
60. J.L. Gutierrez-Chico, E. Regar, and E. Nuesch Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents in vivo assessment with optical coherence tomography Circulation 124 5 2011 612 623
61. A. Farb, A.P. Burke, F.D. Kolodgie, and R. Virmani Pathological mechanisms of fatal late coronary stent thrombosis in humans Circulation 108 14 2003 1701 1706
62. Y. Onuma, and P.W. Serruys ABSORB EXTEND and Cohort B unstable angina subset PCR focus group on bioresorbable vascular scaffolds March 2012 [Rotterdam NL]
63. R. Diletti, Y. Onuma, and V. Farooq 6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm J Am Coll Cardiol 58 3 2011 258 264
64. V. Farooq, Y. Onuma, and M. Radu Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application EuroIntervention 7 3 2011 386 399
65. V. Farooq, J. Gomez-Lara, and S. Brugaletta Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold Catheter Cardiovasc Interv 79 6 2012 880 888
66. J.A. Ormiston, F. De Vroey, P.W. Serruys, and M.W. Webster Bioresorbable polymeric vascular scaffolds: a cautionary tale Circ Cardiovasc Interv 4 5 2011 535 538
67. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 7 Feb 22 2011 779 797